Michael Douglas

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Axons 60%
3. Retinal Ganglion Cells 45%
4. Cerebrospinal Fluid 44%
5. Blood Platelets 43%
6. Central Nervous System 37%
7. Immunoreceptor Tyrosine-Based Inhibition Motif 35%
8. Megakaryocytes 33%
9. Regeneration 33%
10. Myelin Sheath 32%
11. Spinal Ganglia 30%
12. Neuronal Outgrowth 29%
13. opicinumab 26%
14. Growth 26%
15. Stromal Cells 24%
16. Apoptosis 24%
17. citron-kinase 24%
18. ErbB Receptors 23%
19. Neuroglia 23%
20. Non-Receptor Type 6 Protein Tyrosine Phosphatase 23%
21. phosphatidylinositol 3,5-diphosphate 21%
22. Nerve Growth Factors 20%
23. sialic acid receptor 20%
24. C-Type Lectins 19%
25. Primary Myelofibrosis 19%
26. Phospholipase C gamma 18%
27. Neurons 18%
28. Nervous System Trauma 18%
29. Tyrosine 18%
30. Actin Depolymerizing Factors 17%
31. Platelet Endothelial Cell Adhesion Molecule-1 17%
32. Immunoglobulin Light Chains 16%
33. T-Lymphocytes 16%
34. src-Family Kinases 16%
35. RTKI cpd 16%
36. Spinal Injections 15%
37. Pericytes 15%
38. Heparitin Sulfate 15%
39. Guillain-Barre Syndrome 15%
40. Osmotic Pressure 14%
41. Survivin 14%
42. 4-hydroxy-5-nitrophenyl acetic acid 14%
43. Th1 Cells 14%
44. Vascular Cell Adhesion Molecule-1 14%
45. Diagnosis-Related Groups 13%
46. Metabolomics 13%
47. Parkinsonian Disorders 13%
48. Sedentary Behavior 13%
49. Proteins 13%
50. Integrins 13%